Research & Development

Research & Development

Related Links

 

“"The biology around SAP regulation of innate immune system control of fibrotic processes is very exciting. We are going to change the way people  think about impacting this disease process.”

– Mark Lupher, Ph D. 
 Vice President, 
 Drug Discovery

The Biology of Fibrosis

Fibrosis results from deregulation of the wound healing processes.  There are three stages to the wound healing process: initiation, propagation and resolution.  Fibrosis results from chronic stimulation of initiation, amplification of propagation and insufficient stimulation and recruitment of resolution responses.

There is emerging recognition in the scientific field that there are two types of immune responses to injury that regulate these three stages of wound healing and thereby fibrosis. There is a primary inflammatory immune response that functions to clean and sterilize the wound; however this process also generates damaged tissue.  This damaged tissue can promote initiation of fibrotic changes, and can stimulate a secondary pro-fibrotic immune response that amplifies the propagation stage.  Finally resolution of scar tissue is now recognized to require recruitment of certain primary inflammatory immune cell populations.

Research has shown that traditional non-specific anti-inflammatory drugs are ineffective at blocking progression of fibrotic disease.  However, these agents only affect the primary inflammatory immune response.  They do not appear to affect the secondary pro-fibrotic immune response and may actually inhibit recruitment of the resolution response.